Drug Shortage Report for SCLERODINE 6 INJECTION
Report ID | 38171 |
Drug Identification Number | 02020793 |
Brand name | SCLERODINE 6 INJECTION |
Common or Proper name | Sclerodine |
Company Name | OMEGA LABORATORIES LIMITED |
Market Status | DORMANT |
Active Ingredient(s) | IODINE SODIUM IODIDE |
Strength(s) | 60MG 90MG |
Dosage form(s) | LIQUID |
Route of administration | INTRAVENOUS |
Packaging size | 5 X 10mL |
ATC code | C05BB |
ATC description | ANTIVARICOSE THERAPY |
Reason for shortage | Shortage of an inactive ingredient or component. |
Anticipated start date | 2018-02-01 |
Actual start date | 2018-02-01 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2018-02-02 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
Company contact information | info@omegalaboratory.com - 1-800-363-0584 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2018-02-02 | French | Compare |
v1 | 2018-02-02 | English | Compare |
Showing 1 to 2 of 2